What is the ticker symbol for Liminatus Pharma?

Liminatus Pharma trades under the ticker LIMN on NASDAQ.

What sector does Liminatus Pharma operate in?

Liminatus Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LIMN in a portfolio?

PortView shows LIMN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Liminatus Pharma (LIMN) Stock Analysis

NASDAQHealthcareBiotechnology

$3.74+2.56%

1-year price historyRange $3.65 – $149.00

52-week range$3.74

$3.42$154.50

What Liminatus Pharma does

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

Key metrics

Market cap

$5.02M

P/E (TTM)

-20.77

EPS (TTM)

$-0.18

Beta

0.74

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$5.59

200-day avg

$19.21

52-week high

$154.50

52-week low

$3.42

CEO

Chris Kim

ETFs linked to LIMN

Broad-market and Healthcare sector ETFs an investor holding Liminatus Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LIMN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LIMN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Liminatus Pharma?: Liminatus Pharma trades under the ticker LIMN on NASDAQ.
Which exchange is LIMN listed on?: LIMN is listed on NASDAQ.
What sector does Liminatus Pharma operate in?: Liminatus Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LIMN in a portfolio?: PortView shows LIMN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.